Top compounds associated with response to PCSK1N


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.19 6e-08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.15 6e-06
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.17 1e-05
Download CSV